bloods_vldlcholcal il6

Histogram

Visit number vs Epinephrine
N Mean StdDev Median Min Max Unknown Total
Baseline 49 2.5 ± 1.3 2.1 0.7 5.7 - 49
9-Month Followup 42 7.3 ± 5.6 5.3 1.7 22.7 1 43
18-Month Followup 39 6.2 ± 4.4 4.7 1.1 16.0 1 40
Randomized treatment arm vs Epinephrine
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 49 2.5 ± 1.3 2.1 0.7 5.7 - 49
Laparoscopic Gastric Banding (LGB) 28 2.3 ± 1.0 2.1 0.7 4.9 - 28
Continuous Positive Airway Pressure (CPAP) 21 2.9 ± 1.6 2.6 1.0 5.7 - 21
Randomized treatment arm vs Epinephrine
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 42 7.3 ± 5.6 5.3 1.7 22.7 1 43
Laparoscopic Gastric Banding (LGB) 24 6.8 ± 5.6 5.1 1.7 22.7 1 25
Continuous Positive Airway Pressure (CPAP) 18 8.0 ± 5.6 6.4 2.3 20.5 - 18
Randomized treatment arm vs Epinephrine
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 39 6.2 ± 4.4 4.7 1.1 16.0 1 40
Laparoscopic Gastric Banding (LGB) 24 6.0 ± 4.6 4.4 1.1 16.0 - 24
Continuous Positive Airway Pressure (CPAP) 15 6.4 ± 4.2 5.9 1.5 15.1 1 16
Age of the participant vs Epinephrine
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 49 2.5 ± 1.3 2.1 0.7 5.7 - 49
27.0 to 45.0 years 13 3.0 ± 1.6 2.7 1.0 5.7 - 13
46.0 to 50.0 years 12 2.7 ± 1.0 2.6 1.4 5.1 - 12
51.0 to 56.0 years 12 2.3 ± 1.1 1.9 1.2 4.9 - 12
57.0 to 65.0 years 12 2.1 ± 1.2 1.8 0.7 4.3 - 12
Age of the participant vs Epinephrine
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 42 7.3 ± 5.6 5.3 1.7 22.7 1 43
28.0 to 47.0 years 11 7.1 ± 5.5 5.2 2.3 20.5 - 11
47.0 to 52.0 years 11 7.7 ± 5.9 6.1 2.2 18.9 - 11
52.0 to 58.0 years 11 6.3 ± 5.8 5.1 1.7 22.7 - 11
58.0 to 65.0 years 9 8.3 ± 5.9 6.3 2.4 20.7 1 10
Age of the participant vs Epinephrine
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 39 6.2 ± 4.4 4.7 1.1 16.0 1 40
29.0 to 46.0 years 10 6.4 ± 4.4 5.3 1.5 15.1 - 10
47.0 to 52.0 years 9 6.7 ± 4.5 7.3 2.0 15.7 1 10
53.0 to 58.0 years 10 3.8 ± 2.3 3.1 1.1 8.4 - 10
58.0 to 65.0 years 10 7.8 ± 5.3 6.1 1.4 16.0 - 10
Gender of the participant vs Epinephrine
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 49 2.5 ± 1.3 2.1 0.7 5.7 - 49
Male 28 2.7 ± 1.3 2.2 1.0 5.7 - 28
Female 21 2.3 ± 1.2 2.0 0.7 5.1 - 21
Gender of the participant vs Epinephrine
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 42 7.3 ± 5.6 5.3 1.7 22.7 1 43
Male 25 8.2 ± 5.6 6.5 2.2 22.7 - 25
Female 17 5.9 ± 5.4 4.3 1.7 20.7 1 18
Gender of the participant vs Epinephrine
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 39 6.2 ± 4.4 4.7 1.1 16.0 1 40
Male 25 7.3 ± 4.7 6.4 1.5 16.0 - 25
Female 14 4.2 ± 3.1 3.7 1.1 12.3 1 15
Race of the participant vs Epinephrine
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 46 2.6 ± 1.3 2.2 0.7 5.7 - 46
white 35 2.4 ± 1.3 2.0 0.9 5.7 - 35
american indian or alaska native - - - - - - - -
black or african american 9 2.7 ± 1.1 2.7 0.7 4.0 - 9
asian 2 4.7 ± 0.5 4.7 4.3 5.1 - 2
native hawaiian or other pacific islander - - - - - - - -
other - - - - - - - -
multiple - - - - - - - -
Race of the participant vs Epinephrine
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 39 7.4 ± 5.8 5.2 1.7 22.7 1 40
white 30 7.4 ± 6.1 5.1 1.7 22.7 1 31
american indian or alaska native - - - - - - - -
black or african american 8 7.0 ± 4.8 6.0 2.4 16.6 - 8
asian 1 10.6 - 10.6 10.6 10.6 - 1
native hawaiian or other pacific islander - - - - - - - -
other - - - - - - - -
multiple - - - - - - - -
Race of the participant vs Epinephrine
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 36 6.3 ± 4.5 4.7 1.4 16.0 1 37
white 28 5.8 ± 4.2 4.3 1.4 15.7 1 29
american indian or alaska native - - - - - - - -
black or african american 7 7.0 ± 4.6 5.2 2.6 16.0 - 7
asian 1 15.1 - 15.1 15.1 15.1 - 1
native hawaiian or other pacific islander - - - - - - - -
other - - - - - - - -
multiple - - - - - - - -